Regulatory Consulting for Cell Therapies
Regulatory strategy built around your cell therapy.
About
About
Made Scientific’s regulatory team works with cell therapy developers on agency meetings and submissions, from early nonclinical studies through commercial approval worldwide.
Because we also develop, manufacture, and test cell therapies, our regulatory advice starts from how yours is made. You keep ownership of your filings and your program.
Services
Services
Regulatory assessment and gap analysis
Agency meetings, from request to follow-up
IND, BLA, and CMC submissions
CMC strategy
Global regulatory strategy
Our Capabilities
From a first IND to a BLA, we prepare the CMC content reviewers look at most closely, along with the rest of your submission.
Regulatory Assessment
Where your program stands.
Development pathway and target product profile
Expedited program evaluation
Risk-based development planning
Regulatory intelligence
Agency Meetings
You go in prepared, communicate clearly, and act on the feedback.
INTERACT, Pre-IND, End of Phase 1 and 2
EMA Scientific Advice and PRIME
Briefing books and rehearsal
Post-meeting analysis
IND Preparation
Support for a first filing and beyond.
Authoring and compilation support for Modules 2 and 3
eCTD submission preparation
Amendments and IND maintenance
BLA Preparation
Support through approval and after.
Submission strategy
Module 2 Quality Overall Summary
Module 3 CMC documentation
Annual reports and periodic updates
CMC Strategy
CMC work built for living cell products.
Phase-appropriate CMC development planning
Critical quality attributes
Comparability strategies
Process validation planning
Global Strategy
Building for more than one market from the start avoids repeat work later.
FDA and EMA
PMDA, Health Canada, and MHRA
Common Technical Document preparation
Support at the moments that matter
Taking a cell therapy to the clinic for the first time is a lot to manage. You get a defined path from discovery to IND.
Regulatory education, roadmaps tied to financing milestones, academic-to-industry translation, right-sized quality systems, regulatory operations setup, and due diligence support for fundraising, partnerships, and licensing.
You follow one development strategy across regions and see where requirements differ, with coordinated development strategy, region-specific gap analysis, and ICH guideline alignment.
Why Made Scientific for Regulatory
Starts from how it’s made
Because we also develop, manufacture, and test cell therapies, our advice starts from how yours is made.
Agency experience at every step
From request letters and briefing books through attendance and next steps.
Built for living products
Donor eligibility, potency assay development, and cellular characterization.
Your program stays yours
You keep ownership of your regulatory filings and your program.
Regulatory Insights
Technical perspectives from Made Scientific.
Structuring your quality by design framework
A Made Scientific article on building quality by design into cell therapy development.
Read Article
Strategies for a successful tech transfer
A Made Scientific article on moving a cell therapy process between teams and sites.
Read ArticleMade is easy to work with. We’ve got your back.
We work as an extension of your team. Cell therapy development is rarely linear, so our engagement models are designed to flex with your program as timelines shift and data evolves.
Traditional & Dedicated Service
All Clients
We provide end-to-end solutions with platform processes or purpose-built technology transfer, plus dedicated capacity models to secure your supply chain.
Hybrid Client-In-Plant Operations
Mid-to-Late Stage Clients
We get you started, then step back. GMP-ready labs, cleanrooms, and equipment are available in shared or dedicated settings, supported by specialized experts.
Custom Build-outs & Partnerships
Late-Stage and Commercial Clients
We collaborate on custom lab, cleanroom, warehousing, and cold-chain solutions tailored to your workflow and spatial needs in our expansion areas.
From First Filing to Global Expansion
Tell us where your program stands and where you intend to file. We’ll build a regulatory plan around your cell therapy, timeline, and target markets.